TCL Archive In Brief: Indiana U. Planning “World Class” Cancer Center; UCLA Names Two New Cancer Control Directors June 6, 1986
TCL Archive Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups September 30, 1988
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer. February 22, 2008